Lincoln Pharmaceuticals
Lincoln Pharmaceuticals Performance
Day Range
- Low 671.00
- High 689.00
52 Week Range
- Low 300.00
- High 692.00
- Open Price685.00
- Previous Close672.65
- Volume100662
Start SIP in Lincoln Pharmaceuticals
Start SIPLincoln Pharmaceuticals Investment Rating
-
Master Rating:
-
Lincoln Pharmaceuticals has an operating revenue of Rs. 537.83 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 20% is great, ROE of 14% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 23% and 53% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 23% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 85 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has great fundamentals and technical strength to stay in momentum.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 156 | 136 | 112 | 134 | 141 | 123 | 103 |
Operating Expenses Qtr Cr | 125 | 115 | 96 | 107 | 112 | 107 | 85 |
Operating Profit Qtr Cr | 31 | 21 | 17 | 27 | 29 | 17 | 17 |
Depreciation Qtr Cr | 3 | 3 | 2 | 2 | 2 | 2 | 2 |
Interest Qtr Cr | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
Tax Qtr Cr | 9 | 6 | 4 | 9 | 8 | 6 | 6 |
Net Profit Qtr Cr | 28 | 19 | 13 | 22 | 24 | 15 | 11 |
Lincoln Pharmaceuticals Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹615.75
- 50 Day
- ₹563.81
- 100 Day
- ₹517.02
- 200 Day
- ₹461.96
- 20 Day
- ₹612.07
- 50 Day
- ₹547.07
- 100 Day
- ₹504.46
- 200 Day
- ₹440.04
Lincoln Pharmaceuticals Resistance and Support
Resistance | |
---|---|
First Resistance | 687.57 |
Second Resistance | 697.28 |
Third Resistance | 705.57 |
RSI | 73.95 |
MFI | 83.77 |
MACD Single Line | 33.43 |
MACD | 37.82 |
Support | |
---|---|
First Resistance | 669.57 |
Second Resistance | 661.28 |
Third Resistance | 651.57 |
Lincoln Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 106,560 | 5,179,882 | 48.61 |
Week | 146,606 | 6,098,799 | 41.6 |
1 Month | 355,293 | 8,733,090 | 24.58 |
6 Month | 166,910 | 6,859,989 | 41.1 |
Lincoln Pharmaceuticals Result Highlights
Lincoln Pharmaceuticals Synopsis
NSE-Medical-Diversified
Lincoln Pharmace is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 510.31 Cr. and Equity Capital is Rs. 20.03 Cr. for the Year ended 31/03/2023. Lincoln Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 20/01/1995 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ1995PLC024288 and registration number is 024288.Market Cap | 1,358 |
Sales | 538 |
Shares in Float | 0.98 |
No of funds | 12 |
Yield | 0.23 |
Book Value | 2.71 |
U/D Vol ratio | 4 |
LTDebt / Equity | |
Alpha | 0.25 |
Beta | 0.9 |
Lincoln Pharmaceuticals
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 50.53% | 48.67% | 47% | 46.34% |
Mutual Funds | ||||
Foreign Portfolio Investors | 2.59% | 1.74% | 1.27% | 1.44% |
Individual Investors | 37.47% | 37.32% | 37.04% | 36.61% |
Others | 9.41% | 12.27% | 14.69% | 15.61% |
Lincoln Pharmaceuticals Management
Name | Designation |
---|---|
Mr. Kishor M Shah | Chairman |
Mr. Mahendra G Patel | Managing Director |
Mr. Hashmukh I Patel | Whole Time Director |
Mr. Munjal M Patel | Whole Time Director |
Mr. Ashish R Patel | Whole Time Director |
Mr. Rajnikant G Patel | Director |
Mr. Ishwarlal A Patel | Independent Director |
Mr. Pirabhai R Suthar | Independent Director |
Mr. Meha M Patel | Independent Director |
Mr. Saurin J Parikh | Independent Director |
Lincoln Pharmaceuticals Forecast
Price Estimates
Lincoln Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-11-02 | Quarterly Results | |
2023-08-10 | Quarterly Results | |
2023-05-25 | Audited Results & Dividend | |
2023-02-09 | Quarterly Results | |
2022-11-10 | Quarterly Results |
Lincoln Pharmaceuticals FAQs
What is Share Price of Lincoln Pharmaceuticals ?
Lincoln Pharmaceuticals share price is ₹677 As on 01 December, 2023 | 22:14
What is the Market Cap of Lincoln Pharmaceuticals ?
The Market Cap of Lincoln Pharmaceuticals is ₹1357.7 Cr As on 01 December, 2023 | 22:14
What is the P/E ratio of Lincoln Pharmaceuticals ?
The P/E ratio of Lincoln Pharmaceuticals is 16.8 As on 01 December, 2023 | 22:14
What is the PB ratio of Lincoln Pharmaceuticals ?
The PB ratio of Lincoln Pharmaceuticals is 2.7 As on 01 December, 2023 | 22:14